Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.
Identifieur interne : 000F30 ( PubMed/Curation ); précédent : 000F29; suivant : 000F31Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.
Auteurs : K B Wong [Hong Kong] ; D C C. Wan [Hong Kong] ; H F Chow [Hong Kong]Source :
- Hong Kong medical journal = Xianggang yi xue za zhi [ 1024-2708 ] ; 2014.
Descripteurs français
- KwdFr :
- Acides aminés, Concentration inhibitrice 50, Conception de médicament, Cysteine endopeptidases, Inhibiteurs de protéases (synthèse chimique), Oligopeptides (synthèse chimique), Peptidomimétiques (synthèse chimique), Protéines virales (antagonistes et inhibiteurs), Spécificité du substrat, Structure moléculaire, Virus du SRAS (enzymologie).
- MESH :
- antagonistes et inhibiteurs : Protéines virales.
- enzymologie : Virus du SRAS.
- synthèse chimique : Inhibiteurs de protéases, Oligopeptides, Peptidomimétiques.
- Acides aminés, Concentration inhibitrice 50, Conception de médicament, Cysteine endopeptidases, Spécificité du substrat, Structure moléculaire.
English descriptors
- KwdEn :
- Amino Acids, Cysteine Endopeptidases, Drug Design, Inhibitory Concentration 50, Molecular Structure, Oligopeptides (chemical synthesis), Peptidomimetics (chemical synthesis), Protease Inhibitors (chemical synthesis), SARS Virus (enzymology), Substrate Specificity, Viral Proteins (antagonists & inhibitors).
- MESH :
- chemical , antagonists & inhibitors : Viral Proteins.
- chemical , chemical synthesis : Oligopeptides, Peptidomimetics, Protease Inhibitors.
- chemical : Amino Acids, Cysteine Endopeptidases.
- enzymology : SARS Virus.
- Drug Design, Inhibitory Concentration 50, Molecular Structure, Substrate Specificity.
PubMed: 25224113
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F30
Links to Exploration step
pubmed:25224113Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.</title>
<author><name sortKey="Wong, K B" sort="Wong, K B" uniqKey="Wong K" first="K B" last="Wong">K B Wong</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Life Sciences, The Chinese University of Hong Kong.</nlm:affiliation>
<country>Hong Kong</country>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author><name sortKey="Wan, D C C" sort="Wan, D C C" uniqKey="Wan D" first="D C C" last="Wan">D C C. Wan</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Biomedical Sciences, The Chinese University of Hong Kong.</nlm:affiliation>
<country>Hong Kong</country>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author><name sortKey="Chow, H F" sort="Chow, H F" uniqKey="Chow H" first="H F" last="Chow">H F Chow</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Chemistry, The Chinese University of Hong Kong.</nlm:affiliation>
<country>Hong Kong</country>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25224113</idno>
<idno type="pmid">25224113</idno>
<idno type="wicri:Area/PubMed/Corpus">000F30</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F30</idno>
<idno type="wicri:Area/PubMed/Curation">000F30</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F30</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.</title>
<author><name sortKey="Wong, K B" sort="Wong, K B" uniqKey="Wong K" first="K B" last="Wong">K B Wong</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Life Sciences, The Chinese University of Hong Kong.</nlm:affiliation>
<country>Hong Kong</country>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author><name sortKey="Wan, D C C" sort="Wan, D C C" uniqKey="Wan D" first="D C C" last="Wan">D C C. Wan</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Biomedical Sciences, The Chinese University of Hong Kong.</nlm:affiliation>
<country>Hong Kong</country>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author><name sortKey="Chow, H F" sort="Chow, H F" uniqKey="Chow H" first="H F" last="Chow">H F Chow</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Chemistry, The Chinese University of Hong Kong.</nlm:affiliation>
<country>Hong Kong</country>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Hong Kong medical journal = Xianggang yi xue za zhi</title>
<idno type="ISSN">1024-2708</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acids</term>
<term>Cysteine Endopeptidases</term>
<term>Drug Design</term>
<term>Inhibitory Concentration 50</term>
<term>Molecular Structure</term>
<term>Oligopeptides (chemical synthesis)</term>
<term>Peptidomimetics (chemical synthesis)</term>
<term>Protease Inhibitors (chemical synthesis)</term>
<term>SARS Virus (enzymology)</term>
<term>Substrate Specificity</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acides aminés</term>
<term>Concentration inhibitrice 50</term>
<term>Conception de médicament</term>
<term>Cysteine endopeptidases</term>
<term>Inhibiteurs de protéases (synthèse chimique)</term>
<term>Oligopeptides (synthèse chimique)</term>
<term>Peptidomimétiques (synthèse chimique)</term>
<term>Protéines virales (antagonistes et inhibiteurs)</term>
<term>Spécificité du substrat</term>
<term>Structure moléculaire</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Oligopeptides</term>
<term>Peptidomimetics</term>
<term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Amino Acids</term>
<term>Cysteine Endopeptidases</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Inhibiteurs de protéases</term>
<term>Oligopeptides</term>
<term>Peptidomimétiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Design</term>
<term>Inhibitory Concentration 50</term>
<term>Molecular Structure</term>
<term>Substrate Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Acides aminés</term>
<term>Concentration inhibitrice 50</term>
<term>Conception de médicament</term>
<term>Cysteine endopeptidases</term>
<term>Spécificité du substrat</term>
<term>Structure moléculaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25224113</PMID>
<DateCompleted><Year>2015</Year>
<Month>06</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1024-2708</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>20 Suppl 4</Volume>
<PubDate><Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hong Kong medical journal = Xianggang yi xue za zhi</Title>
<ISOAbbreviation>Hong Kong Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.</ArticleTitle>
<Pagination><MedlinePgn>18-21</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>K B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences, The Chinese University of Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wan</LastName>
<ForeName>D C C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo><Affiliation>School of Biomedical Sciences, The Chinese University of Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chow</LastName>
<ForeName>H F</ForeName>
<Initials>HF</Initials>
<AffiliationInfo><Affiliation>Department of Chemistry, The Chinese University of Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>China</Country>
<MedlineTA>Hong Kong Med J</MedlineTA>
<NlmUniqueID>9512509</NlmUniqueID>
<ISSNLinking>1024-2708</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000598688">Cbz-AVLQ-CN</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057786">Peptidomimetics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="C099456">3C-like proteinase, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057786" MajorTopicYN="Y">Peptidomimetics</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011480" MajorTopicYN="Y">Protease Inhibitors</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25224113</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F30 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000F30 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25224113 |texte= Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25224113" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |